With the successful translation of cell and gene therapies into the clinic, demand for viral vectors has increased significantly. As a result, the need for scalable, cost-effective viral vector manufacturing processes and improved methods of purification and analytics, has become apparent.
- Key manufacturing differences between the two most used viral vectors
- Analytics and release testing in the viral vector workflow
